Fisher & Paykel Healthcare Corporation Limited (FRA:FPLB)

Market Cap	11.02B -4.6%
Revenue (ttm)	1.14B +14.2%
Net Income	232.18M +24.2%
EPS	0.39 +24.1%
Shares Out	n/a
PE Ratio	47.47
Forward PE	39.85
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	18.50
Previous Close	18.50
Day's Range	18.50 - 18.50
52-Week Range	16.00 - 20.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 25, 2026

About FRA:FPLB

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilatio...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1934
• Employees: 7,396
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FPLB

Financial Performance

In fiscal year 2026, FRA:FPLB's revenue was 2.31 billion, an increase of 14.22% compared to the previous year's 2.02 billion. Earnings were 468.50 million, an increase of 24.20%.

Financial numbers in NZD